A Multicenter, Prospective Study to Evaluate the Risk of Hypothyroidism in Pediatric Patients Administered Intravascular Iohexol, Iodixanol, or Iopromide
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2018
At a glance
- Drugs Iodixanol (Primary) ; Iodixanol (Primary) ; Iohexol (Primary) ; Iopromide (Primary)
- Indications Cardiovascular disorders; Gastrointestinal disorders
- Focus Adverse reactions
- Sponsors GE Healthcare
- 24 Aug 2018 Planned End Date changed from 1 Apr 2025 to 1 Dec 2023.
- 24 Aug 2018 Planned primary completion date changed from 1 Apr 2024 to 1 Aug 2023.
- 24 Aug 2018 Planned initiation date changed from 1 Nov 2018 to 1 Feb 2019.